PHENTERMINE HCL capsule

देश: संयुक्त राज्य

भाषा: अंग्रेज़ी

स्रोत: NLM (National Library of Medicine)

सक्रिय संघटक:

PHENTERMINE HYDROCHLORIDE (UNII: 0K2I505OTV) (PHENTERMINE - UNII:C045TQL4WP)

थमां उपलब्ध:

Northwind Pharmaceuticals

INN (इंटरनेशनल नाम):

PHENTERMINE HYDROCHLORIDE

रचना:

PHENTERMINE HYDROCHLORIDE 15 mg

प्रशासन का मार्ग:

ORAL

प्रिस्क्रिप्शन प्रकार:

PRESCRIPTION DRUG

चिकित्सीय संकेत:

Phentermine Hydrochloride, USP 15 mg and 30 mg is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m2, or greater than or equal to 27 kg/m2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. View image at Permanent Link listed below. The limited usefulness of agents of this class, including Phentermine hydrochloride, [see CLINICAL PHARMACOLOGY ( 12.1, 12.2)] should be measured against possible risk factors inherent in their use such as those described below. Please rev

उत्पाद समीक्षा:

Phentermine Hydrochloride capsules, USP are available as follows: Phentermine Hydrochloride capsules, USP 15 mg are supplied as gray opaque cap, rich yellow opaque body with black imprint “K 26” on both the cap and body, filled with powder. Bottles of 30, NDC 10702-026-03 Bottles of 100, NDC 10702-026-01 Bottles of 1000, NDC 10702-026-10 Phentermine Hydrochloride capsules, USP 30 mg are supplied as rich yellow opaque cap, rich yellow opaque body with black imprint “K 27” on both the cap and body, filled with powder. Bottles of 30, NDC 10702-027-03 Bottles of 100, NDC 10702-027-01 Bottles of 1000, NDC 10702-027-10 Phentermine Hydrochloride capsules, USP 30 mg are supplied as blue cap, natural body with black imprint “K 28” on both the cap and body, filled with white and blue colored beads. Bottles of 30, NDC 10702-028-03 Bottles of 100, NDC 10702-028-01 Bottles of 1000, NDC 10702-028-10 Store at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light resistant container as defined in the USP, with a child-resistant closure (as required). Keep out of the reach of children Please review the manufacturer's complete drug information available from the FDA at www.fda.gov Permanent Link: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b963f7bb-fa65-4e28-81c9-282fbe70a6a6

प्राधिकरण का दर्जा:

Abbreviated New Drug Application

उत्पाद विशेषताएं

PHENTERMINE HCL- PHENTERMINE HCL CAPSULE
NORTHWIND PHARMACEUTICALS
----------
PHENTERMINE HCL 15MG
INDICATIONS AND USAGE
Phentermine Hydrochloride, USP 15 mg and 30 mg is indicated as a
short-term (a few weeks) adjunct in
a regimen of weight reduction based on exercise, behavioral
modification and caloric restriction in the
management of exogenous obesity for patients with an initial body mass
index greater than or equal to
30 kg/m2, or greater than or equal to 27 kg/m2 in the presence of
other risk factors (e.g., controlled
hypertension, diabetes, hyperlipidemia).
Below is a chart of Body Mass Index (BMI) based on various heights and
weights.
BMI is calculated by taking the patient’s weight, in kilograms (kg),
divided by the patient’s height, in
meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2
= kg; inches x 0.0254 = meters.
View image at Permanent Link listed below.
The limited usefulness of agents of this class, including Phentermine
hydrochloride, [see CLINICAL
PHARMACOLOGY ( 12.1, 12.2)] should be measured against possible risk
factors inherent in their use
such as those described below.
Please review the manufacturer's complete drug information available
from the FDA at www.fda.gov
Permanent Link:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b963f7bb-fa65-4e28-81c9-
282fbe70a6a6
DOSAGE AND ADMINISTRATION
2.1 Exogenous Obesity
Dosage should be individualized to obtain an adequate response with
the lowest effective dose.
The usual adult dose is 15 mg to 30 mg at approximately 2 hours after
breakfast for appetite control.
Late evening medication should be avoided because of the possibility
of resulting insomnia.
Administration of one capsule (30 mg) daily has been found to be
adequate in depression of the appetite
for 12 to 14 hours.
Phentermine is not recommended for use in patients 16 years of age and
under.
Late Evening medication should be avoided because of the possibility
of resulting insomnia.
2.2 Dosage in Patients With Renal Impairment
The recommended maximum dosag